StonvexLoading…
StonvexCore line items from BNZI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-12 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $3.96M | $2.70M | $12.16M | $9.35M | $6.64M |
Operating Income | Not available | $-5.78M | $-18.46M | $-14.18M | $-9.61M |
Net Income | Not available | $-8.42M | $-22.49M | $-17.46M | $-7.93M |
EPS (Diluted) | $-6.83 | $-11.69 | $-5.95 | $-7.74 | $-7.24 |
Total Assets | Not available | $31.47M | $31.63M | $32.99M | $34.68M |
Total Liabilities | Not available | $23.38M | $23.58M | $27.55M | $31.52M |
Cash & Equivalents | Not available | $137.00K | $259.00K | $851.36K | $2.25M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 867.36K | 527.32K | 5.21M | 2.48M |